Body dysmorphic disorder symptoms among patients with acne vulgaris.

Body dysmorphic disorder symptoms among patients with acne vulgaris. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Body dysmorphic disorder symptoms among patients with acne vulgaris. Abstract Text:

Whitney P Bowe,James J Leyden,Canice E Crerand,David B Sarwer,David J Margolis,

BACKGROUND: Acne is one of the most common concerns of patients with body dysmorphic disorder (BDD), a psychiatric condition defined as a preoccupation with a slight or imagined defect in appearance that causes significant disruption in daily functioning. OBJECTIVE: We sought to screen for BDD symptoms among patients with acne across a spectrum of acne severity. METHODS: We used a validated self-report questionnaire and an objective assessment of acne severity by a single observer. RESULTS: Rates of BDD ranged from 14.1% using more stringent criteria to assess acne severity to 21.1% using less stringent criteria. Two-fold increased odds of having BDD was seen in patients requiring systemic isotretinoin therapy. LIMITATIONS: Cross-sectional study design is a limitation. CONCLUSION: A significant proportion of patients, regardless of their acne severity at the time of examination, have substantial distress and preoccupation related to their facial appearance.

Body dysmorphic disorder symptoms among patients with acne vulgaris. Publishing Authors By Initials

WP Bowe,JJ Leyden,CE Crerand,DB Sarwer,DJ Margolis,

For similar mental disorders: somatoform disorders research abstracts see: mental disorders: somatoform disorders research

PUBMED ID PMID:

MEDLINE DATE:

Body dysmorphic disorder symptoms among patients with acne vulgaris. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of the American Academy of Dermatology

VOLUME: 57

Page Numbers: 222-30

Journal Abbreviation: J. Am. Acad. Dermatol.

ISSN: 1097-6787

DAY: 10

MONTH: 05

YEAR: 2007

Body dysmorphic disorder symptoms among patients with acne vulgaris. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7907132

Body dysmorphic disorder symptoms among patients with acne vulgaris. Keywords Mesh Terms:

KEYWORDS: Somatoform Disorders

MESH TERMS: psychology

Chemical & Substance for Abstract: Body dysmorphic disorder symptoms among patients with acne vulgaris. Information

Substance Name: Isotretinoin

Registry Number: 4759-48-2

Grant and Affiliation Information for Body dysmorphic disorder symptoms among patients with acne vulgaris.

AFFILIATION: Department of Dermatology, The Children's Hospital of Philadelphia, USA.

Country: United States

AGENCY: United States NIAMS

GRANT: K24-AR02212

ACRONYM: AR

MEDLINETA: J Am Acad Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Body dysmorphic disorder symptoms among patients with acne vulgaris Related Publications

• "Steel wool keratopathy": a clinical sign of chronic inflammation.
• A novel Crumbs3 isoform regulates cell division and ciliogenesis via importin beta interactions.
• A novel trinucleotide repeat expansion at chromosome 3q26.2 identified by a CAG/CTG repeat expansion detection array.
• Apical junctional complexes and cell polarity.
• Bex1 knock out mice show altered skeletal muscle regeneration.
• Body dysmorphic disorder symptoms among patients with acne vulgaris.
• Confronting proviral HIV infection.
• Digital imaging of wounds: are measurements reproducible among observers?
• Effect of fluoride on artificial caries lesion progression and repair in human enamel: regulation of mineral deposition and dissolution under in vivo-like conditions.
• Emergency medical services education: past, present, and future.
• Expression of an intron-containing beta-tubulin mRNA in catfish olfactory epithelium.
• Hepatitis B vaccination of men who have sex with men attending an urban STD clinic: impact of an ongoing vaccination program, 1998-2003.
• Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
• Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
• Mammalian lin-7 stabilizes polarity protein complexes.
• Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed.
• Nuclear receptors and bone.
• Obituary: arun fotedar.
• Olfactory marker protein modulates the cAMP kinetics of the odour-induced response in cilia of mouse olfactory receptor neurons.
• PALS1 regulates E-cadherin trafficking in mammalian epithelial cells.
• Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations.
• Repeat expansion and autosomal dominant neurodegenerative disorders: consensus and controversy.
• Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis.
• Sensate scaffolds coupled to telemetry can monitor in vivo loading from within a joint over extended periods of time.
• Sodium/calcium exchanger expression in the mouse and rat olfactory systems.
• Spindle cell lipoma of the mediastinum: a differential consideration for liposarcoma.
• The prevalence of atopic triad in children with physician-confirmed atopic dermatitis.
• Upper respiratory tract infection in household contacts of acne patients.
• c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.
• pH triggered self-assembly of native and recombinant amelogenins under physiological pH and temperature in vitro.